ArticleReproduction (Cambridge, England)2025
Characterization of the expression of XPR1 in ovine utero-placental tissues.
Article in Reproduction (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
In brief: Phosphate plays a critical role in conceptus development, yet the mechanisms regulating utero-placental availability remain underinvestigated. This research characterized the spatiotemporal expression and endocrine regulation of XPR1, a phosphate exporter, in ovine utero-placental tissues, suggesting a potential role of XPR1 in the regulation of utero-placental phosphate availability. Abstract: Phosphate is an essential regulator of conceptus development, but there is limited understanding of mechanisms regulating phosphate availability in utero-placental tissues. These experiments characterized the expression of xenotropic and polytropic retrovirus receptor 1 (XPR1), a phosphate exporter, in ovine utero-placental tissues. In Experiment 1, ewes were hysterectomized on day 1, 9, or 14 of the estrous cycle or day 30, 50, 70, 110, or 125 of pregnancy. Day of the estrous cycle did not affect XPR1 mRNA expression or protein localization. Expression of XPR1 mRNA decreased with day of gestation in placentomes, while XPR1 protein was detectable in uterine epithelia, blood vessels, endometrial stromal cells, myometrium, caruncular stroma, and syncytium of the placentome. In Experiment 2, ewes received daily injections of either corn oil vehicle (CO) or 25 mg progesterone (P4) in vehicle for the first 8 days of pregnancy and were hysterectomized on either day 9, 12, or 125. Endometrial stroma from P4-treated ewes had greater XPR1 immunoreactivity than CO-treated ewes on day 9. On day 125, endometria from P4-treated ewes had decreased expression of XPR1 mRNA compared to CO-treated ewes. Greater XPR1 protein immunoreactivity was present in uterine epithelia and stratum compactum stroma of P4-treated than CO-treated ewes. P4-treated ewes with a singleton fetus tended to have greater expression of XPR1 mRNA in placentomes than CO-treated ewes with a singleton fetus. Collectively, these results suggest a potential role of XPR1 in the regulation of phosphate availability in utero-placental tissues in ruminants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.